Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy

The BCL-2 protein family determines the commitment of cells to apoptosis, an ancient cell suicide programme that is essential for development, tissue homeostasis and immunity. Too little apoptosis can promote cancer and autoimmune diseases; too much apoptosis can augment ischaemic conditions and drive neurodegeneration. We discuss the biochemical, structural and genetic studies that have clarified how the interplay between members of the BCL-2 family on mitochondria sets the apoptotic threshold. These mechanistic insights into the functions of the BCL-2 family are illuminating the physiological control of apoptosis, the pathological consequences of its dysregulation and the promising search for novel cancer therapies that target the BCL-2 family.

[1]  S. Cory,et al.  ABT-199, a new Bcl-2-specific BH3 mimetic, has in vivo efficacy against aggressive Myc-driven mouse lymphomas without provoking thrombocytopenia. , 2013, Blood.

[2]  A. Strasser,et al.  E mu-bcl-2 transgene facilitates spontaneous transformation of early pre-B and immunoglobulin-secreting cells but not T cells. , 1993, Oncogene.

[3]  Xiaodong Wang,et al.  Smac, a Mitochondrial Protein that Promotes Cytochrome c–Dependent Caspase Activation by Eliminating IAP Inhibition , 2000, Cell.

[4]  A. Strasser,et al.  BH3-only proteins Puma and Bim are rate-limiting for gamma-radiation- and glucocorticoid-induced apoptosis of lymphoid cells in vivo. , 2005, Blood.

[5]  P. Nowell,et al.  Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. , 1984, Science.

[6]  K. Roth,et al.  Mcl-1 deficiency results in peri-implantation embryonic lethality. , 2000, Genes & development.

[7]  G. Gores,et al.  Selectively targeting Mcl-1 for the treatment of acute myelogenous leukemia and solid tumors. , 2012, Genes & development.

[8]  Erinna F. Lee,et al.  Discovery and molecular characterization of a Bcl-2–regulated cell death pathway in schistosomes , 2011, Proceedings of the National Academy of Sciences.

[9]  Osamu Takeuchi,et al.  BID, BIM, and PUMA Are Essential for Activation of the BAX- and BAK-Dependent Cell Death Program , 2010, Science.

[10]  W. Zong,et al.  BH3-only proteins that bind pro-survival Bcl-2 family members fail to induce apoptosis in the absence of Bax and Bak. , 2001, Genes & development.

[11]  A. Strasser,et al.  Fatal hepatitis mediated by tumor necrosis factor TNFalpha requires caspase-8 and involves the BH3-only proteins Bid and Bim. , 2009, Immunity.

[12]  A. Letai,et al.  Regulation of Bcl-2 family proteins by posttranslational modifications. , 2008, Current molecular medicine.

[13]  Christian Goess,et al.  The Bcl-2 Family Antagonist ABT-737 Significantly Inhibits Multiple Animal Models of Autoimmunity , 2009, The Journal of Immunology.

[14]  A. Keating,et al.  Structure-based redesign of the binding specificity of anti-apoptotic Bcl-x(L). , 2013, Journal of molecular biology.

[15]  S. Armstrong,et al.  Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members. , 2006, Cancer cell.

[16]  A. Strasser,et al.  The BCL-2 protein family: opposing activities that mediate cell death , 2008, Nature Reviews Molecular Cell Biology.

[17]  Y. Pang,et al.  Transient binding of an activator BH3 domain to the Bak BH3-binding groove initiates Bak oligomerization , 2011, The Journal of cell biology.

[18]  A. Strasser,et al.  Degenerative disorders caused by Bcl-2 deficiency prevented by loss of its BH3-only antagonist Bim. , 2001, Developmental cell.

[19]  Jian Yu,et al.  Targeting Bax interaction sites reveals that only homo-oligomerization sites are essential for its activation , 2013, Cell Death and Differentiation.

[20]  Derek Y. Chiang,et al.  The landscape of somatic copy-number alteration across human cancers , 2010, Nature.

[21]  C. Croce,et al.  The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. , 1985, Science.

[22]  W. D. Fairlie,et al.  Vaccinia virus anti-apoptotic F1L is a novel Bcl-2-like domain-swapped dimer that binds a highly selective subset of BH3-containing death ligands , 2008, Cell Death and Differentiation.

[23]  A. Strasser,et al.  Puma cooperates with Bim, the rate-limiting BH3-only protein in cell death during lymphocyte development, in apoptosis induction , 2006, The Journal of experimental medicine.

[24]  J. Opferman,et al.  Deletion of MCL-1 causes lethal cardiac failure and mitochondrial dysfunction. , 2013, Genes & development.

[25]  D. Green,et al.  A unified model of mammalian BCL-2 protein family interactions at the mitochondria. , 2011, Molecular cell.

[26]  S. Geley,et al.  Targeting antiapoptotic A1/Bfl-1 by in vivo RNAi reveals multiple roles in leukocyte development in mice. , 2012, Blood.

[27]  A. Strasser,et al.  Puma and to a lesser extent Noxa are suppressors of Myc-induced lymphomagenesis , 2009, Cell Death and Differentiation.

[28]  G. Salvesen,et al.  The apoptosome: signalling platform of cell death , 2007, Nature Reviews Molecular Cell Biology.

[29]  Osamu Takeuchi,et al.  Stepwise activation of BAX and BAK by tBID, BIM, and PUMA initiates mitochondrial apoptosis. , 2009, Molecular cell.

[30]  A. Strasser,et al.  Apoptosis Regulators Fas and Bim Cooperate in Shutdown of Chronic Immune Responses and Prevention of Autoimmunity , 2008, Immunity.

[31]  Sun-Hee Lee,et al.  Contribution of Bcl-2 phosphorylation to Bak binding and drug resistance. , 2013, Cancer research.

[32]  David L. Vaux,et al.  An evolutionary perspective on apoptosis , 1994, Cell.

[33]  A. Strasser,et al.  Alternative splicing of Bim and Erk-mediated BimEL phosphorylation are dispensable for hematopoietic homeostasis in vivo , 2012, Cell Death and Differentiation.

[34]  S. Korsmeyer,et al.  Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death , 1993, Cell.

[35]  S. Korsmeyer,et al.  Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and Death , 2001, Science.

[36]  E. Stanley,et al.  Proapoptotic BH3-Only Bcl-2 Family Member Bik/Blk/Nbk Is Expressed in Hemopoietic and Endothelial Cells but Is Redundant for Their Programmed Death , 2004, Molecular and Cellular Biology.

[37]  Hao Xiong,et al.  Substantial susceptibility of chronic lymphocytic leukemia to BCL2 inhibition: results of a phase I study of navitoclax in patients with relapsed or refractory disease. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[38]  S. Korsmeyer,et al.  Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair , 1993, Cell.

[39]  Takahiro Suzuki,et al.  Hepatocyte-specific disruption of Bcl-xL leads to continuous hepatocyte apoptosis and liver fibrotic responses. , 2004, Gastroenterology.

[40]  L. Lam,et al.  ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets , 2013, Nature Medicine.

[41]  S. Pattingre,et al.  JNK1-mediated phosphorylation of Bcl-2 regulates starvation-induced autophagy. , 2008, Molecular cell.

[42]  B. Hyman,et al.  Apoptotic and non-apoptotic roles of caspases in neuronal physiology and pathophysiology , 2012, Nature Reviews Neuroscience.

[43]  A. Strasser,et al.  Maximal killing of lymphoma cells by DNA damage-inducing therapy requires not only the p53 targets Puma and Noxa, but also Bim. , 2010, Blood.

[44]  G. Dewson,et al.  Molecular biology of Bax and Bak activation and action. , 2011, Biochimica et biophysica acta.

[45]  Erinna F. Lee,et al.  Evaluation of diverse α/β-backbone patterns for functional α-helix mimicry: analogues of the Bim BH3 domain. , 2012, Journal of the American Chemical Society.

[46]  Junying Yuan,et al.  Alternative cell death mechanisms in development and beyond. , 2010, Genes & development.

[47]  E. White,et al.  Key roles of BIM-driven apoptosis in epithelial tumors and rational chemotherapy. , 2005, Cancer cell.

[48]  D. Green,et al.  BID-induced structural changes in BAK promote apoptosis , 2013, Nature Structural &Molecular Biology.

[49]  A. Strasser,et al.  Gefitinib-Induced Killing of NSCLC Cell Lines Expressing Mutant EGFR Requires BIM and Can Be Enhanced by BH3 Mimetics , 2007, PLoS medicine.

[50]  A. Strasser,et al.  BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes , 2002, Nature.

[51]  D. Green,et al.  The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of Apoptosis , 1997, Science.

[52]  A. Strasser,et al.  Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. , 1999, Science.

[53]  D. Vaux,et al.  Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[54]  H. Steinhoff,et al.  Molecular Details of Bax Activation, Oligomerization, and Membrane Insertion* , 2009, The Journal of Biological Chemistry.

[55]  A. Letai,et al.  Diagnosing and exploiting cancer's addiction to blocks in apoptosis , 2008, Nature Reviews Cancer.

[56]  Xu Luo,et al.  A three-helix homo-oligomerization domain containing BH3 and BH1 is responsible for the apoptotic activity of Bax. , 2007, Genes & development.

[57]  Arthur E. Johnson,et al.  Bax Forms an Oligomer via Separate, Yet Interdependent, Surfaces* , 2010, The Journal of Biological Chemistry.

[58]  Emiko Fire,et al.  The MCL-1 BH3 Helix is an Exclusive MCL-1 inhibitor and Apoptosis Sensitizer , 2010, Nature chemical biology.

[59]  J. Martinou,et al.  Mitochondria in apoptosis: Bcl-2 family members and mitochondrial dynamics. , 2011, Developmental cell.

[60]  A. Strasser,et al.  Treatment of B-RAF mutant human tumor cells with a MEK inhibitor requires Bim and is enhanced by a BH3 mimetic. , 2008, The Journal of clinical investigation.

[61]  A. García-Sáez,et al.  Mechanistic differences in the membrane activity of Bax and Bcl-xL correlate with their opposing roles in apoptosis. , 2013, Biophysical journal.

[62]  S. Korsmeyer,et al.  The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues. , 2000, Molecular cell.

[63]  Jerry E. Chipuk,et al.  The Role of BH3-Only Proteins in Tumor Cell Development, Signaling, and Treatment. , 2011, Genes & cancer.

[64]  S. Korsmeyer,et al.  Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis , 1999, Nature.

[65]  H. Horvitz,et al.  The Caenorhabditis elegans cell death gene ced-4 encodes a novel protein and is expressed during the period of extensive programmed cell death. , 1992, Development.

[66]  David L. Vaux,et al.  Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells , 1988, Nature.

[67]  N. Tjandra,et al.  BAX Activation is Initiated at a Novel Interaction Site , 2008, Nature.

[68]  A. Strasser,et al.  Activated T cell death in vivo mediated by proapoptotic bcl-2 family member bim. , 2002, Immunity.

[69]  P. Bouillet,et al.  Bim is a suppressor of Myc-induced mouse B cell leukemia. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[70]  L. Walensky,et al.  Direct activation of full-length proapoptotic BAK , 2013, Proceedings of the National Academy of Sciences.

[71]  D. Andrews,et al.  Apoptosis: embedded in membranes. , 2010, Current opinion in cell biology.

[72]  D. Green,et al.  Mitochondria and cell death: outer membrane permeabilization and beyond , 2010, Nature Reviews Molecular Cell Biology.

[73]  Lin Chen,et al.  Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins. , 2005, Genes & development.

[74]  Daniel P. Stewart,et al.  Anti-apoptotic MCL-1 localizes to the mitochondrial matrix and couples mitochondrial fusion to respiration , 2012, Nature Cell Biology.

[75]  H. Tagawa,et al.  Genome-wide array-based CGH for mantle cell lymphoma: identification of homozygous deletions of the proapoptotic gene BIM , 2005, Oncogene.

[76]  W. Zong,et al.  Bfl-1/A1 functions, similar to Mcl-1, as a selective tBid and Bak antagonist , 2008, Oncogene.

[77]  S. Edwards,et al.  Mcl‐1; the molecular regulation of protein function , 2010, FEBS letters.

[78]  C. Day,et al.  Bak activation for apoptosis involves oligomerization of dimers via their alpha6 helices. , 2009, Molecular cell.

[79]  Herman I. May,et al.  Exercise-induced BCL2-regulated autophagy is required for muscle glucose homeostasis , 2012, Nature.

[80]  Junying Yuan,et al.  Solution Structure of BID, an Intracellular Amplifier of Apoptotic Signaling , 1999, Cell.

[81]  Erinna F. Lee,et al.  Structural insights into the degradation of Mcl-1 induced by BH3 domains , 2007, Proceedings of the National Academy of Sciences.

[82]  A. Strasser,et al.  Consequences of the combined loss of BOK and BAK or BOK and BAX , 2013, Cell Death and Disease.

[83]  Erinna F. Lee,et al.  Conformational Changes in Bcl-2 Pro-survival Proteins Determine Their Capacity to Bind Ligands* , 2009, The Journal of Biological Chemistry.

[84]  Brian A. Chauder,et al.  Discovery of potent myeloid cell leukemia 1 (Mcl-1) inhibitors using fragment-based methods and structure-based design. , 2013, Journal of medicinal chemistry.

[85]  E. Stanley,et al.  Hrk/DP5 contributes to the apoptosis of select neuronal populations but is dispensable for haematopoietic cell apoptosis , 2007, Journal of Cell Science.

[86]  K. Kinzler,et al.  PUMA induces the rapid apoptosis of colorectal cancer cells. , 2001, Molecular cell.

[87]  J. Risk,et al.  Bim, Bad and Bmf: intrinsically unstructured BH3-only proteins that undergo a localized conformational change upon binding to prosurvival Bcl-2 targets , 2007, Cell Death and Differentiation.

[88]  J. Zha,et al.  Navitoclax Enhances the Efficacy of Taxanes in Non–Small Cell Lung Cancer Models , 2011, Clinical Cancer Research.

[89]  A. Aplin,et al.  Mcl-1 Is Required for Melanoma Cell Resistance to Anoikis , 2009, Molecular Cancer Research.

[90]  P. Ekert,et al.  Programmed Anuclear Cell Death Delimits Platelet Life Span , 2007, Cell.

[91]  K. Nakayama,et al.  Accelerated Neutrophil Apoptosis in Mice Lacking A1-a, a Subtype of the bcl-2–related A1 Gene , 1998, The Journal of experimental medicine.

[92]  S. Korsmeyer,et al.  Solution Structure of the Proapoptotic Molecule BID A Structural Basis for Apoptotic Agonists and Antagonists , 1999, Cell.

[93]  S. Kiryu-Seo,et al.  Critical Role for DP5/Harakiri, a Bcl-2 Homology Domain 3-Only Bcl-2 Family Member, in Axotomy-Induced Neuronal Cell Death , 2004, The Journal of Neuroscience.

[94]  C. Ploner,et al.  Suppression of B-cell lymphomagenesis by the BH3-only proteins Bmf and Bad. , 2010, Blood.

[95]  T. Kuwana,et al.  BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly. , 2005, Molecular cell.

[96]  A. Strasser,et al.  The BH3-Only Protein Bid Is Dispensable for DNA Damage- and Replicative Stress-Induced Apoptosis or Cell-Cycle Arrest , 2007, Cell.

[97]  D. Andrews,et al.  Bax forms multispanning monomers that oligomerize to permeabilize membranes during apoptosis , 2005, The EMBO journal.

[98]  Brian J. Smith,et al.  Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. , 2005, Molecular cell.

[99]  R. Hotchkiss,et al.  Cell death. , 2009, The New England journal of medicine.

[100]  John Calvin Reed,et al.  A survey of the anti-apoptotic Bcl-2 subfamily expression in cancer types provides a platform to predict the efficacy of Bcl-2 antagonists in cancer therapy , 2010, Cell Death and Disease.

[101]  G. Giovinazzo,et al.  Myc-driven endogenous cell competition in the early mammalian embryo , 2013, Nature.

[102]  C. Streuli,et al.  Bax Exists in a Dynamic Equilibrium between the Cytosol and Mitochondria to Control Apoptotic Priming , 2013, Molecular cell.

[103]  S. Korsmeyer,et al.  Bax Loss Impairs Myc-Induced Apoptosis and Circumvents the Selection of p53 Mutations during Myc-Mediated Lymphomagenesis , 2001, Molecular and Cellular Biology.

[104]  D. Huang,et al.  BH3 mimetics antagonizing restricted prosurvival Bcl-2 proteins represent another class of selective immune modulatory drugs , 2010, Proceedings of the National Academy of Sciences.

[105]  S. Srinivasula,et al.  Cytochrome c and dATP-Dependent Formation of Apaf-1/Caspase-9 Complex Initiates an Apoptotic Protease Cascade , 1997, Cell.

[106]  P. Colman,et al.  BCL-2 family antagonists for cancer therapy , 2008, Nature Reviews Drug Discovery.

[107]  W. Zong,et al.  Deficiency in Bak and Bax perturbs thymic selection and lymphoid homeostasis , 2002, Nature Immunology.

[108]  G. Dewson,et al.  Bax dimerizes via a symmetric BH3:groove interface during apoptosis , 2011, Cell Death and Differentiation.

[109]  A. Strasser,et al.  Individual and overlapping roles of BH3-only proteins Bim and Bad in apoptosis of lymphocytes and platelets and in suppression of thymic lymphoma development , 2010, Cell Death and Differentiation.

[110]  Christoph Borner,et al.  XIAP discriminates between type I and type II FAS-induced apoptosis , 2009, Nature.

[111]  Robert L Moritz,et al.  Identification of DIABLO, a Mammalian Protein that Promotes Apoptosis by Binding to and Antagonizing IAP Proteins , 2000, Cell.

[112]  A. Strasser,et al.  Loss of BH3-only Protein Bim Inhibits Apoptosis of Hemopoietic Cells in the Fetal Liver and Male Germ Cells but Not Neuronal Cells in Bcl-x-deficient Mice , 2008, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[113]  D. Tenen,et al.  BIM Mediates EGFR Tyrosine Kinase Inhibitor-Induced Apoptosis in Lung Cancers with Oncogenic EGFR Mutations , 2007, PLoS medicine.

[114]  M. Nöthen,et al.  A common BIM deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancer , 2012, Nature Medicine.

[115]  S. Korsmeyer,et al.  BCLW mediates survival of postmitotic Sertoli cells by regulating BAX activity. , 2001, Developmental biology.

[116]  P. Marrack,et al.  The structure of a Bcl-xL/Bim fragment complex: implications for Bim function. , 2003, Immunity.

[117]  A. Strasser,et al.  BCL-2 family member BOK is widely expressed but its loss has only minimal impact in mice , 2012, Cell Death and Differentiation.

[118]  al. et,et al.  Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice , 1995, Science.

[119]  Shai Shaham,et al.  The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme , 1993, Cell.

[120]  S. Korsmeyer,et al.  Mutagenesis of the BH3 Domain of BAX Identifies Residues Critical for Dimerization and Killing , 1998, Molecular and Cellular Biology.

[121]  C. Scott,et al.  The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized. , 2006, Cancer cell.

[122]  R. Meadows,et al.  Structure of Bcl-xL-Bak Peptide Complex: Recognition Between Regulators of Apoptosis , 1997, Science.

[123]  R. Youle,et al.  Role of Bax and Bak in mitochondrial morphogenesis , 2006, Nature.

[124]  Andreas Villunger,et al.  p53- and Drug-Induced Apoptotic Responses Mediated by BH3-Only Proteins Puma and Noxa , 2003, Science.

[125]  A. Strasser,et al.  Ultraviolet radiation triggers apoptosis of fibroblasts and skin keratinocytes mainly via the BH3-only protein Noxa , 2007, The Journal of cell biology.

[126]  C. Goodnow.  Multistep Pathogenesis of Autoimmune Disease , 2007, Cell.

[127]  B. Göttgens,et al.  Epigenetic silencing of BIM in glucocorticoid poor-responsive pediatric acute lymphoblastic leukemia, and its reversal by histone deacetylase inhibition. , 2010, Blood.

[128]  S. Kaufmann,et al.  Context-dependent Bcl-2/Bak Interactions Regulate Lymphoid Cell Apoptosis* , 2009, The Journal of Biological Chemistry.

[129]  Michael T. Certo,et al.  Chronic lymphocytic leukemia requires BCL2 to sequester prodeath BIM, explaining sensitivity to BCL2 antagonist ABT-737. , 2007, The Journal of clinical investigation.

[130]  A. Strasser,et al.  Loss of the BH3-only protein Bmf impairs B cell homeostasis and accelerates γ irradiation–induced thymic lymphoma development , 2008, The Journal of experimental medicine.

[131]  Erinna F. Lee,et al.  Bax Crystal Structures Reveal How BH3 Domains Activate Bax and Nucleate Its Oligomerization to Induce Apoptosis , 2013, Cell.

[132]  D. Andrews,et al.  Membrane Binding by tBid Initiates an Ordered Series of Events Culminating in Membrane Permeabilization by Bax , 2008, Cell.

[133]  Erinna F. Lee,et al.  Bcl-2, Bcl-x(L), and Bcl-w are not equivalent targets of ABT-737 and navitoclax (ABT-263) in lymphoid and leukemic cells. , 2012, Blood.

[134]  S. R. Datta,et al.  Bad-deficient mice develop diffuse large B cell lymphoma , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[135]  S. Korsmeyer,et al.  Obligate Role of Anti-Apoptotic MCL-1 in the Survival of Hematopoietic Stem Cells , 2005, Science.

[136]  S. Korsmeyer,et al.  Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1 , 2003, Nature.

[137]  S. Akira,et al.  Integral role of Noxa in p53-mediated apoptotic response. , 2003, Genes & development.

[138]  R. Meadows,et al.  X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death , 1996, Nature.

[139]  B. Corfe,et al.  Cell Damage-induced Conformational Changes of the Pro-Apoptotic Protein Bak In Vivo Precede the Onset of Apoptosis , 1999, The Journal of cell biology.

[140]  A. Strasser,et al.  Concomitant loss of proapoptotic BH3‐only Bcl‐2 antagonists Bik and Bim arrests spermatogenesis , 2005, The EMBO journal.

[141]  Erinna F. Lee,et al.  Anti-apoptotic Mcl-1 is essential for the development and sustained growth of acute myeloid leukemia. , 2012, Genes & development.

[142]  C. Tse,et al.  ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor. , 2008, Cancer research.

[143]  T. McDonnell,et al.  Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18) , 1991, Nature.

[144]  C. Scott,et al.  Elevated Mcl-1 perturbs lymphopoiesis, promotes transformation of hematopoietic stem/progenitor cells, and enhances drug resistance. , 2010, Blood.

[145]  P. Colman,et al.  To trigger apoptosis, Bak exposes its BH3 domain and homodimerizes via BH3:groove interactions. , 2008, Molecular cell.

[146]  Erinna F. Lee,et al.  Mutation to Bax beyond the BH3 Domain Disrupts Interactions with Pro-survival Proteins and Promotes Apoptosis* , 2011, The Journal of Biological Chemistry.

[147]  G. Cohen,et al.  BIM-Mediated Membrane Insertion of the BAK Pore Domain Is an Essential Requirement for Apoptosis , 2013, Cell reports.

[148]  Stefan P. Glaser,et al.  Mcl-1 is essential for the survival of plasma cells , 2013, Nature Immunology.

[149]  Erinna F. Lee,et al.  The role of BH3-only protein Bim extends beyond inhibiting Bcl-2–like prosurvival proteins , 2009, The Journal of cell biology.

[150]  S. Korsmeyer,et al.  An inhibitor of Bcl-2 family proteins induces regression of solid tumours , 2005, Nature.

[151]  M. Hinds,et al.  Structural plasticity underpins promiscuous binding of the prosurvival protein A1. , 2008, Structure.

[152]  S. Cory,et al.  The Bcl-2 apoptotic switch in cancer development and therapy , 2007, Oncogene.

[153]  Brian J. Smith,et al.  Structure-guided design of a selective BCL-X(L) inhibitor. , 2013, Nature chemical biology.

[154]  Erinna F. Lee,et al.  Crystal structure of ABT-737 complexed with Bcl-xL: implications for selectivity of antagonists of the Bcl-2 family , 2007, Cell Death and Differentiation.

[155]  K. Vousden,et al.  PUMA, a novel proapoptotic gene, is induced by p53. , 2001, Molecular cell.

[156]  C. Scott,et al.  In vivo efficacy of the Bcl-2 antagonist ABT-737 against aggressive Myc-driven lymphomas , 2008, Proceedings of the National Academy of Sciences.

[157]  Xiaodong Wang,et al.  Apaf-1, a Human Protein Homologous to C. elegans CED-4, Participates in Cytochrome c–Dependent Activation of Caspase-3 , 1997, Cell.

[158]  D. Andrews,et al.  Mechanisms of action of Bcl-2 family proteins. , 2013, Cold Spring Harbor perspectives in biology.

[159]  S. Korsmeyer,et al.  Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. , 2002, Cancer cell.

[160]  Ryung S. Kim,et al.  Conformational Changes in BAK, a Pore-forming Proapoptotic Bcl-2 Family Member, upon Membrane Insertion and Direct Evidence for the Existence of BH3-BH3 Contact Interface in BAK Homo-oligomers* , 2010, The Journal of Biological Chemistry.

[161]  Chengyu Liang,et al.  Evidence that inhibition of BAX activation by BCL-2 involves its tight and preferential interaction with the BH3 domain of BAX , 2011, Cell Research.

[162]  A. Letai,et al.  Pretreatment Mitochondrial Priming Correlates with Clinical Response to Cytotoxic Chemotherapy , 2011, Science.

[163]  J. Cleveland,et al.  Puma is an essential mediator of p53-dependent and -independent apoptotic pathways. , 2003, Cancer cell.

[164]  Mark A Sussman,et al.  Loss of MCL-1 leads to impaired autophagy and rapid development of heart failure. , 2013, Genes & development.

[165]  Suzanne Cory,et al.  bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship , 1991, Cell.

[166]  A. Strasser,et al.  Loss of the Pro-Apoptotic BH3-only Bcl-2 Family Member Bim Inhibits BCR Stimulation–induced Apoptosis and Deletion of Autoreactive B Cells , 2003, The Journal of experimental medicine.

[167]  A. Strasser,et al.  Proapoptotic BH3-only protein Bim is essential for developmentally programmed death of germinal center-derived memory B cells and antibody-forming cells. , 2007, Blood.

[168]  A. Strasser,et al.  Unleashing the power of inhibitors of oncogenic kinases through BH3 mimetics , 2009, Nature Reviews Cancer.

[169]  S. Nagata,et al.  Autoimmunity and the Clearance of Dead Cells , 2010, Cell.

[170]  Evripidis Gavathiotis,et al.  A stapled BIM peptide overcomes apoptotic resistance in hematologic cancers. , 2012, The Journal of clinical investigation.

[171]  J. Hsieh,et al.  Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies , 2006, Nature Cell Biology.

[172]  L. Walensky,et al.  BH3-triggered structural reorganization drives the activation of proapoptotic BAX. , 2010, Molecular cell.

[173]  Nico Tjandra,et al.  Bcl-xL Retrotranslocates Bax from the Mitochondria into the Cytosol , 2011, Cell.

[174]  Nico Tjandra,et al.  Structure of Bax Coregulation of Dimer Formation and Intracellular Localization , 2000, Cell.

[175]  G. Kroemer,et al.  Bcl-2 family members: dual regulators of apoptosis and autophagy. , 2008, Autophagy.

[176]  A. Strasser,et al.  Shutdown of an acute T cell immune response to viral infection is mediated by the proapoptotic Bcl-2 homology 3-only protein Bim , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[177]  D. Green,et al.  Cytoplasmic functions of the tumour suppressor p53 , 2009, Nature.

[178]  F. Bazan,et al.  Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival , 2010, Nature.

[179]  A. Strasser,et al.  Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2 , 1990, Nature.

[180]  H. Horvitz,et al.  C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2 , 1994, Cell.

[181]  S. Korsmeyer,et al.  bcl-2-Immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation , 1989, Cell.

[182]  A. Strasser,et al.  Bim and Bad mediate imatinib-induced killing of Bcr/Abl+ leukemic cells, and resistance due to their loss is overcome by a BH3 mimetic , 2006, Proceedings of the National Academy of Sciences.

[183]  A. Strasser,et al.  DNA damage-induced primordial follicle oocyte apoptosis and loss of fertility require TAp63-mediated induction of Puma and Noxa. , 2012, Molecular cell.

[184]  B. Gillissen,et al.  Frequent loss of expression of the pro-apoptotic protein Bim in renal cell carcinoma: evidence for contribution to apoptosis resistance , 2007, Oncogene.

[185]  A. García-Sáez,et al.  Proapoptotic Bax and Bak Proteins Form Stable Protein-permeable Pores of Tunable Size , 2013, The Journal of Biological Chemistry.

[186]  M. Hengartner,et al.  Caenorhabditis elegans gene ced-9 protects cells from programmed cell death , 1992, Nature.

[187]  Erinna F. Lee,et al.  Apoptosis Initiated When BH3 Ligands Engage Multiple Bcl-2 Homologs, Not Bax or Bak , 2007, Science.

[188]  A. Villunger,et al.  Minor cell death defects but reduced tumor latency in mice lacking the BH3-only proteins Bad and Bmf , 2012, Oncogene.

[189]  C. Print,et al.  Apoptosis regulator bcl-w is essential for spermatogenesis but appears otherwise redundant. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[190]  A. Letai,et al.  Relative Mitochondrial Priming of Myeloblasts and Normal HSCs Determines Chemotherapeutic Success in AML , 2012, Cell.

[191]  M. Skinner,et al.  Testicular degeneration in Bclw-deficient mice , 1998, Nature Genetics.

[192]  Erinna F. Lee,et al.  INAUGURAL ARTICLE by a Recently Elected Academy Member:Apoptosis is triggered when prosurvival Bcl-2 proteins cannot restrain Bax , 2008 .

[193]  Mark A. Hall,et al.  Selection against PUMA Gene Expression in Myc-Driven B-Cell Lymphomagenesis , 2008, Molecular and Cellular Biology.

[194]  A. Strasser,et al.  Foxo‐mediated Bim transcription is dispensable for the apoptosis of hematopoietic cells that is mediated by this BH3‐only protein , 2013, EMBO reports.

[195]  A. Wyllie,et al.  Apoptosis: A Basic Biological Phenomenon with Wide-ranging Implications in Tissue Kinetics , 1972, British Journal of Cancer.

[196]  L. Walensky,et al.  Direct and selective small-molecule activation of proapoptotic BAX. , 2012, Nature chemical biology.

[197]  A. Tocilj,et al.  The X-ray structure of a BAK homodimer reveals an inhibitory zinc binding site. , 2006, Molecular cell.

[198]  D. Andrews,et al.  Shedding Light on Apoptosis at Subcellular Membranes , 2012, Cell.

[199]  J. Opferman,et al.  Delving deeper: MCL-1's contributions to normal and cancer biology. , 2013, Trends in cell biology.

[200]  D. Green,et al.  The BCL-2 family reunion. , 2010, Molecular cell.

[201]  A. Strasser,et al.  Deciphering the rules of programmed cell death to improve therapy of cancer and other diseases , 2011, The EMBO journal.

[202]  G. Shore,et al.  Antagonism of Beclin 1‐dependent autophagy by BCL‐2 at the endoplasmic reticulum requires NAF‐1 , 2010, The EMBO journal.

[203]  P. Golstein,et al.  Cell Death in Us and Others , 1998, Science.

[204]  Adam R. Johnson,et al.  Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7 , 2011, Nature.

[205]  Brian J. Smith,et al.  Stabilizing the pro-apoptotic BimBH3 helix (BimSAHB) does not necessarily enhance affinity or biological activity. , 2013, ACS chemical biology.

[206]  Stefan P. Glaser,et al.  Mcl-1 Is Essential for Germinal Center Formation and B Cell Memory , 2010, Science.

[207]  Y. Pang,et al.  Bak Conformational Changes Induced by Ligand Binding: Insight into BH3 Domain Binding and Bak Homo-Oligomerization , 2012, Scientific Reports.

[208]  Y. Hsu,et al.  Nonionic Detergents Induce Dimerization among Members of the Bcl-2 Family* , 1997, The Journal of Biological Chemistry.

[209]  C. Day,et al.  The structure of Boo/Diva reveals a divergent Bcl‐2 protein , 2010, Proteins.

[210]  A. Strasser,et al.  In several cell types tumour suppressor p53 induces apoptosis largely via Puma but Noxa can contribute , 2008, Cell Death and Differentiation.

[211]  Matthew E. Ritchie,et al.  Targeting BCL-2 with the BH3 mimetic ABT-199 in estrogen receptor-positive breast cancer. , 2013, Cancer cell.

[212]  A. Strasser,et al.  The many roles of FAS receptor signaling in the immune system. , 2009, Immunity.

[213]  K. J. Henley,et al.  Proapoptotic Bak and Bax guard against fatal systemic and organ-specific autoimmune disease , 2013, Proceedings of the National Academy of Sciences.

[214]  L. Hennighausen,et al.  Bcl-x and Bax regulate mouse primordial germ cell survival and apoptosis during embryogenesis. , 2000, Molecular endocrinology.

[215]  I. Weissman,et al.  Prevention of programmed cell death in Caenorhabditis elegans by human bcl-2. , 1992, Science.

[216]  Erinna F. Lee,et al.  A novel BH3 ligand that selectively targets Mcl-1 reveals that apoptosis can proceed without Mcl-1 degradation , 2008, The Journal of cell biology.